Jack A. Khattar - 09 Jun 2023 Form 4 Insider Report for COGNITION THERAPEUTICS INC (CGTX)

Role
Director
Signature
/s/ Lisa Ricciardi, Attorney-in-Fact
Issuer symbol
CGTX
Transactions as of
09 Jun 2023
Transactions value $
$0
Form type
4
Filing time
13 Jun 2023, 17:37:18 UTC
Previous filing
08 Jun 2023
Next filing
25 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CGTX Common Stock Award $0 +6K $0.00 6K 09 Jun 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CGTX Stock Option (right to buy) Award $0 +6K $0.00 6K 09 Jun 2023 Common Stock 6K $2.77 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on the earlier of (i) June 9, 2024 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date.
F2 The option vests in full on the earlier of (i) June 9, 2024 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date.